SFRP5 exerts anti-inflammatory effects through the suppression of the non-canonical WNT5/JNK signaling pathway (49, 50), which can stimulate endothelial cell proliferation (51) and vascular calcification (52) associated with the pathogenesis of atherosclerosis. Here, SFRP5 is linked to atherosclerosis.